Skip to main content
Equibles

Dr. Ibrahim B. Dagher

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Ibrahim B. Dagher

Brainstorm Cell Therapeutics Inc. reported in an 8-K filed July 30, 2026 that Dr. Ibrahim B. Dagher resigned as Executive Vice President and Chief Medical Officer, effective July 26, 2026.

“On July 26, 2026, Ibrahim B. Dagher, MD, Executive Vice President and Chief Medical Officer of the Company, resigned from his positions with the Company, effective immediately.”
Brainstorm Cell Therapeutics Inc. Form 8-K, filed July 30, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.